9ELV
Crystal Structure of SARS-CoV-2 Mpro mutant E166V with Pfizer Intravenous Inhibitor PF-00835231
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | NSLS-II BEAMLINE 17-ID-2 |
| Synchrotron site | NSLS-II |
| Beamline | 17-ID-2 |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2023-05-08 |
| Detector | DECTRIS EIGER X 16M |
| Wavelength(s) | 0.987 |
| Spacegroup name | P 1 21 1 |
| Unit cell lengths | 55.321, 99.001, 58.833 |
| Unit cell angles | 90.00, 108.04, 90.00 |
Refinement procedure
| Resolution | 33.740 - 1.620 |
| R-factor | 0.169 |
| Rwork | 0.168 |
| R-free | 0.20340 |
| Structure solution method | MOLECULAR REPLACEMENT |
| RMSD bond length | 0.015 |
| RMSD bond angle | 1.329 |
| Data reduction software | XDS (1.20.1_4487) |
| Data scaling software | XDS |
| Phasing software | PHASER (1.19.2_4158) |
| Refinement software | PHENIX (1.20.1_4487) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 33.740 | 1.678 |
| High resolution limit [Å] | 1.620 | 1.620 |
| Rmerge | 0.019 | 0.278 |
| Number of reflections | 76320 | 7609 |
| <I/σ(I)> | 17.16 | 2.42 |
| Completeness [%] | 99.9 | |
| Redundancy | 2 | |
| CC(1/2) | 1.000 | 0.867 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, HANGING DROP | 5.5 | 293 | 10-20 % (w/v) PEG 3350, 0.20-0.30 M NaCl, and 0.1 M Bis-Tris methane pH 5.5 |






